Evogene Ltd. | CIK:0001574565 | 3

  • Filed: 3/30/2018
  • Entity registrant name: Evogene Ltd. (CIK: 0001574565)
  • Generator: GoXBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/0001178913-18-001042-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/evgn-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001574565
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory

    NOTE 21: -
    OPERATING SEGMENTS

    a.
    General:

    Commencing January 1, 2012, the Company operates in three segments. The segments were determined on the basis of information considered by the Chief Operating Decision-Maker ("CODM") for purposes of decision-making on the allocation of resources and evaluation of performance. The following Company's segments are engaged in business activities for which they earn revenues and incur expenses, their results are reviewed by the CODM and discrete financial information is available:

    Evogene segment
    -
    Develops seed traits, ag-chemical products, and ag-biological products to improve plant performance.
         
    Evofuel segment
    -
    Develops improved castor bean seeds to serve as a feedstock source for biofuel and other industrial uses.
         
    Biomica
    		  -
    Discovery and development of human microbiome-based therapeutics

    Segments performance is determined based on operating loss reported in the financial statements. The results of a segment reported to the CODM include items attributed directly to a segment, as well as other items, which are indirectly attributed using reasonable assumptions.

    b.
    The following table presents our revenues and operating loss by segments:
     
       
    Evogene
    		    
    Evofuel
    		    
    Biomica
    		    
    Adjustments
    		    
    Total
    		  
                                   
    For the Year Ended December 31, 2017
    		                              
                                   
    Revenues
    		  
    $
    3,247
    		    
    $
    134
    		    
    $
    -
    		    
    $
    -
    		    
    $
    3,381
    		  
                                             
    Operating loss
    		  
    $
    (21,430
    )
    		  
    $
    (313
    )
    		  
    $
    (204
    )
    		  
    $
    -
    		    
    $
    (21,947
    )
                                             
    Net financing income
    		                                  
    $
    1,120
    		  
                                             
    Loss before taxes on income
    		                                  
    $
    (20,827
    )

     
       
    Evogene
    		    
    Evofuel
    		    
    Adjustments
    		    
    Total
    		  
                             
    For the Year Ended December 31, 2016
    		                        
                             
    Revenues
    		  
    $
    6,540
    		    
    $
    -
    		    
    $
    -
    		    
    $
    6,540
    		  
                                     
    Operating loss
    		  
    $
    (20,168
    )
    		  
    $
    (921
    )
    		  
    $
    -
    		    
    $
    (21,089
    )
                                     
    Net financing income
    		                            
    1,533
    		  
                                     
    Loss before taxes on income
    		                          
    $
    (19,556
    )
     
       
    Evogene
    		    
    Evofuel
    		    
    Adjustments
    		    
    Total
    		  
                             
    For the Year Ended December 31, 2015
    		                        
                             
    Revenues
    		  
    $
    11,129
    		    
    $
    -
    		    
    $
    -
    		    
    $
    11,129
    		  
                                     
    Operating loss
    		  
    $
    (16,146
    )
    		  
    $
    (1,775
    )
    		  
    $
    -
    		    
    $
    (17,921
    )
                                     
    Net financing income
    		                            
    708
    		  
                                     
    Loss before taxes on income
    		                          
    $
    (17,213
    )

    c.
    Major customers:

    Revenues from major customers each of whom amounts to 10% or more, of total revenues:

       
    Year ended December 31,
    		  
       
    2017
    		    
    2016
    		    
    2015
    		  
                       
    Customer A (shareholder)
    		    
    66
    %
    		    
    77
    %
    		    
    77
    %
    Customer B
    		    
    10
    %
    		    
    12
    %
    		    
    -
    		  
    Customer C
    		    
    *) -
     
    		    
    11
    %
    		    
    14
    %
     
    *) Represents an amount lower than 10%.
     
    See also Note 22 (a).

    d.
    Geographical information:

    Revenues based on the location of the customers, are as follows:

       
    Year ended December 31,
    		  
       
    2017
    		    
    2016
    		    
    2015
    		  
                       
    United States
    		    
    76
    %
    		    
    89
    %
    		    
    86
    %
    Germany
    		    
    10
    %
    		    
    11
    %
    		    
    14
    %
    Other
    		    
    14
    %
    		    
    -
    		      
    -
    		  
                             
         
    100
    %
    		    
    100
    %
    		    
    100
    %